- Collaboration with Merck KGaA, Darmstadt, Germany to evaluate eftilagimod alpha in combination with bintrafusp alfa
- New investigator-initiated explorative, multi-centre, open-labelled Phase I/IIa trial in 12 previously treated patients with different solid tumours, called INSIGHT-005
- First patient is expected to be enrolled and dosed in H2 of calendar year 2021
June 01, 2021 08:00 ET | Source: Immutep Limited
- ...